NCT05292339View on ClinicalTrials.gov

Ketorolac in Upper Extremity Tendinopathy and Arthropathy

PHASE4RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
OsteoarthritisTendinopathyArthropathy
Interventions
DRUG

Triamcinolone injection to the shoulder, elbow, wrist, or hand

Triamcinolone is a corticosteroid that decreases the inflammatory process by inhibiting the release of arachidonic acid from phospholipids.

DRUG

Ketorolac injection to the shoulder, elbow, wrist, or hand

Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that reduces inflammation by inhibiting Cyclo-oxygenase (COX)-2 dependent prostaglandin release via the cyclooxygenase pathway.

Trial Locations (4)

30308

RECRUITING

Emory Saint Joseph's Hospital, Atlanta

30324

RECRUITING

Emory University Orthopaedic and Spine Center, Atlanta

30329

RECRUITING

12 Executive Park Drive, Atlanta

RECRUITING

Emory University Orthopaedic and Spine Hospital, Atlanta

All Listed Sponsors
collaborator

American Association for Hand Surgery: AAHS

UNKNOWN

lead

Emory University

OTHER